EADERM Selected for JETRO’s BIO-Europe 2026 Participation Support Program

EADERM’s Collaboration with Rohto Pharmaceutical featured in Rohto’s Integrated Report 2026

EADERM Co., Ltd. has entered into an exclusive evaluation and license option agreement with ROHTO Pharmaceutical Co., Ltd.

Takehiko Kaneko appointed President and CEO of EADERM Co., Ltd.

EADERM Inc. raises JPY 460 million in Series A financing to accelerate drug discovery and development based on stem cell technology

Article “Development of therapeutics for alopecia” published in Nikkei Biotech

EADERM Inc. raises JPY 50 million in financing from ANRI Inc.